GREGORY L. WEAVER - 02 Mar 2022 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Chief Financial Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact for Gregory L. Weaver
Issuer symbol
ATAI
Transactions as of
02 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Mar 2022, 14:56:03 UTC
Previous filing
07 Jul 2021
Next filing
16 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +228,000 $0.000000 228,000 02 Mar 2022 Common Shares 228,000 $5.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the underlying shares on March 2, 2023 and as to the remaining underlying shares in 36 substantially equal monthly installments thereafter.